Ethical Dilemma for Ebola Drug Testing Trials

1052 Words5 Pages
Ethical Dilemma for Ebola Drug Testing Trials Peyton W. Rumbo CJS/211 February 23, 2015 Paul Noel Ethical Dilemma for Ebola Drug Testing Trials Recently in the news you might have heard about the Ebola break out in Africa, and in the United States. With any new outbreak there is going to be research for a new drug that can hopefully treat the symptoms of Ebola. With many ethical dilemmas scientist will have to face before the new drug can be given to the patients, and the decisions on which drug to use that has the less side effects and the one they have a more supplies of. In the next few paragraphs I will explain the ethical dilemmas, the decisions that were made, alternative courses of action, and the outcome of the new drug. Ethical Dilemma The major ethical dilemma for the drug Zmapp is that the World Health Organization is debating on whether to let some participants be placed in a control group that receives only standard symptomatic treatment, despite a mortality rate of around 70%. The other participants would be getting the new drug and possible getting better. This is a major ethical dilemma, whether to let a lot of people die because you did not give them the drug, or give everyone the drug and hope that it cures them and not kill them because of side effects.(Hayden 2014) “These trials will be conducted in a context of fear, distrust, a lack of effective care options, the admission of multiple family members to the same center, and sometimes violence against health-care workers,” says Peter Horby, an epidemiologist at the University of Oxford, UK. “Scientific arguments cannot tell us what will work in these conditions.” It is a hard decision to make and the United States thinks that every patient should receive the experimental treatment no matter if it’s not any better than standardized treatment. The decision was to use another
Open Document